The Genesis Consortium is setting up to enable a greater range of VCs and corporates to be more active in investing in the future of human and planetary health. Those committed to life science investing are invited to join founding members SOSV IndieBio and Mayfield Capital in creating the Genesis Consortium. Post-COVID, the Genesis Consortium will put together monthly, quarterly, and annual physical events in life sciences investing, with a dinner series focused on relevant and emerging topics of life science breakthroughs; with tech talks and seminars on a frequent basis both at the IndieBio event center in San Francisco and a new IndieBio center opening in New York; and with an annual corporate engagement conference for later stage investors and corporates.
6
Total Investments
6
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
About Genesis Consortium
Recent Investments (6)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Seed Round | •••••• | Sep 2023 | |
| Seed | •••••• | Oct 2022 | |
| Seed Round | •••••• | Sep 2022 | |
| Seed Round | •••••• | Sep 2022 | |
| Pre Seed Round | •••••• | Sep 2022 | |
|
|
Seed Round | •••••• | Sep 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.